Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment por Walter Suárez Carmona | Oct 3, 2025
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial por Walter Suárez Carmona | Oct 3, 2025
Metabolic hallmarks of type 2 diabetes compromise T cell function por Walter Suárez Carmona | Oct 2, 2025
